NCT06938685View on ClinicalTrials.gov

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

NANot yet recruitingINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2026

Conditions

Diabetic Foot Ulcer

Interventions

OTHER

Standard of Care

Wound cleansing, Sharps debridement, Dressing for moisture balance, Offloading

OTHER

NeoThelium FT

NeoThelium FT is a dehydrated wound covering derived from donated human placental tissue. NeoThelium FT is a dual-layer membrane with amnion and chorion combination layers.

Trial Locations (1)

71301

MedCentris of Alexandria, Alexandria

All Listed Sponsors

collaborator

SygNola, LLC

INDUSTRY

lead

NuScience Medical Biologics, LLC

INDUSTRY

NCT06938685 - Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter